Fidelity® Small Cap Enhanced Index Fund
Semi-Annual Report
August 31, 2020
See the inside front cover for important information about access to your fund’s shareholder reports.
Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of a fund’s shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports from the fund or from your financial intermediary, such as a financial advisor, broker-dealer or bank. Instead, the reports will be made available on a website, and you will be notified by mail each time a report is posted and provided with a website link to access the report.
If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. You may elect to receive shareholder reports and other communications from a fund electronically, by contacting your financial intermediary. For Fidelity customers, visit Fidelity's web site or call Fidelity using the contact information listed below.
You may elect to receive all future reports in paper free of charge. If you wish to continue receiving paper copies of your shareholder reports, you may contact your financial intermediary or, if you are a Fidelity customer, visit Fidelity’s website, or call Fidelity at the applicable toll-free number listed below. Your election to receive reports in paper will apply to all funds held with the fund complex/your financial intermediary.
Account Type | Website | Phone Number |
Brokerage, Mutual Fund, or Annuity Contracts: | fidelity.com/mailpreferences | 1-800-343-3548 |
Employer Provided Retirement Accounts: | netbenefits.fidelity.com/preferences (choose 'no' under Required Disclosures to continue to print) | 1-800-343-0860 |
Advisor Sold Accounts Serviced Through Your Financial Intermediary: | Contact Your Financial Intermediary | Your Financial Intermediary's phone number |
Advisor Sold Accounts Serviced by Fidelity: | institutional.fidelity.com | 1-877-208-0098 |
Contents
To view a fund's proxy voting guidelines and proxy voting record for the 12-month period ended June 30, visit http://www.fidelity.com/proxyvotingresults or visit the Securities and Exchange Commission's (SEC) web site at http://www.sec.gov.
You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.
Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.
Other third-party marks appearing herein are the property of their respective owners.
All other marks appearing herein are registered or unregistered trademarks or service marks of FMR LLC or an affiliated company. © 2020 FMR LLC. All rights reserved.
This report and the financial statements contained herein are submitted for the general information of the shareholders of the Fund. This report is not authorized for distribution to prospective investors in the Fund unless preceded or accompanied by an effective prospectus.
A fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. Forms N-PORT are available on the SEC’s web site at http://www.sec.gov. A fund's Forms N-PORT may be reviewed and copied at the SEC’s Public Reference Room in Washington, DC. Information regarding the operation of the SEC's Public Reference Room may be obtained by calling 1-800-SEC-0330.
For a complete list of a fund's portfolio holdings, view the most recent holdings listing, semiannual report, or annual report on Fidelity's web site at http://www.fidelity.com, http://www.institutional.fidelity.com, or http://www.401k.com, as applicable.
NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE
Neither the Fund nor Fidelity Distributors Corporation is a bank.
Note to Shareholders:
Early in 2020, the outbreak and spread of a new coronavirus emerged as a public health emergency that had a major influence on financial markets, primarily based on its impact on the global economy and the outlook for corporate earnings. The virus causes a respiratory disease known as COVID-19. On March 11, the World Health Organization declared the COVID-19 outbreak a pandemic, citing sustained risk of further global spread.
In the weeks following, as the crisis worsened, we witnessed an escalating human tragedy with wide-scale social and economic consequences from coronavirus-containment measures. The outbreak of COVID-19 prompted a number of measures to limit the spread, including travel and border restrictions, quarantines, and restrictions on large gatherings. In turn, these resulted in lower consumer activity, diminished demand for a wide range of products and services, disruption in manufacturing and supply chains, and – given the wide variability in outcomes regarding the outbreak – significant market uncertainty and volatility. Amid the turmoil, the U.S. government took unprecedented action – in concert with the U.S. Federal Reserve and central banks around the world – to help support consumers, businesses, and the broader economy, and to limit disruption to the financial system.
The situation continues to unfold, and the extent and duration of its impact on financial markets and the economy remain highly uncertain. Extreme events such as the coronavirus crisis are “exogenous shocks” that can have significant adverse effects on mutual funds and their investments. Although multiple asset classes may be affected by market disruption, the duration and impact may not be the same for all types of assets.
Fidelity is committed to helping you stay informed amid news about COVID-19 and during increased market volatility, and we’re taking extra steps to be responsive to customer needs. We encourage you to visit our websites, where we offer ongoing updates, commentary, and analysis on the markets and our funds.
Investment Summary (Unaudited)
Top Ten Stocks as of August 31, 2020
| % of fund's net assets |
Deckers Outdoor Corp. | 0.8 |
EMCOR Group, Inc. | 0.7 |
Ufp Industries, Inc. | 0.7 |
EnerSys | 0.7 |
KB Home | 0.7 |
Artisan Partners Asset Management, Inc. | 0.7 |
Synaptics, Inc. | 0.7 |
EVERTEC, Inc. | 0.7 |
Crocs, Inc. | 0.7 |
Cannae Holdings, Inc. | 0.7 |
| 7.1 |
Top Market Sectors as of August 31, 2020
| % of fund's net assets |
Health Care | 19.6 |
Financials | 16.5 |
Industrials | 16.0 |
Information Technology | 15.4 |
Consumer Discretionary | 12.6 |
Real Estate | 4.8 |
Materials | 4.2 |
Utilities | 2.8 |
Consumer Staples | 2.7 |
Communication Services | 2.2 |
Asset Allocation (% of fund's net assets)
As of August 31, 2020* |
| Stocks and Equity Futures | 100.1% |
| Short-Term Investments and Net Other Assets (Liabilities)** | (0.1)% |
* Foreign investments - 4.2%
** Short-Term Investments and Net Other Assets (Liabilities) are not included in the pie chart
Schedule of Investments August 31, 2020 (Unaudited)
Showing Percentage of Net Assets
Common Stocks - 98.8% | | | |
| | Shares | Value |
COMMUNICATION SERVICES - 2.2% | | | |
Diversified Telecommunication Services - 1.2% | | | |
Bandwidth, Inc. (a)(b) | | 11,413 | $1,797,319 |
Cogent Communications Group, Inc. | | 33,685 | 2,265,653 |
Consolidated Communications Holdings, Inc. (a) | | 98,926 | 769,644 |
Iridium Communications, Inc. (a) | | 2,650 | 74,227 |
Liberty Latin America Ltd. Class C (a) | | 25,297 | 241,333 |
Ooma, Inc. (a) | | 36,823 | 502,266 |
PDVWireless, Inc. (a) | | 5,129 | 224,342 |
| | | 5,874,784 |
Entertainment - 0.1% | | | |
Glu Mobile, Inc. (a) | | 52,044 | 413,229 |
Interactive Media & Services - 0.3% | | | |
Liberty TripAdvisor Holdings, Inc. (a) | | 40,098 | 112,274 |
Yelp, Inc. (a) | | 49,714 | 1,149,388 |
Zedge, Inc. (a) | | 19,460 | 27,244 |
| | | 1,288,906 |
Media - 0.3% | | | |
Cardlytics, Inc. (a)(b) | | 11,666 | 884,866 |
comScore, Inc. (a) | | 13,854 | 36,436 |
TechTarget, Inc. (a) | | 7,601 | 301,608 |
Tegna, Inc. | | 14,146 | 177,108 |
| | | 1,400,018 |
Wireless Telecommunication Services - 0.3% | | | |
Shenandoah Telecommunications Co. | | 24,243 | 1,340,638 |
|
TOTAL COMMUNICATION SERVICES | | | 10,317,575 |
|
CONSUMER DISCRETIONARY - 12.6% | | | |
Auto Components - 0.4% | | | |
Adient PLC (a) | | 35,762 | 620,113 |
American Axle & Manufacturing Holdings, Inc. (a) | | 36,093 | 280,804 |
Modine Manufacturing Co. (a) | | 21,137 | 143,097 |
Tenneco, Inc. (a)(b) | | 56,223 | 457,093 |
Visteon Corp. (a) | | 5,941 | 448,130 |
Workhorse Group, Inc. (a)(b) | | 1,521 | 27,545 |
| | | 1,976,782 |
Distributors - 0.2% | | | |
Core-Mark Holding Co., Inc. | | 26,135 | 873,432 |
Diversified Consumer Services - 0.1% | | | |
American Public Education, Inc. (a) | | 2,977 | 93,597 |
Collectors Universe, Inc. | | 2,550 | 113,450 |
Weight Watchers International, Inc. (a) | | 15,185 | 356,544 |
| | | 563,591 |
Hotels, Restaurants & Leisure - 2.5% | | | |
Bloomin' Brands, Inc. (b) | | 84,258 | 1,208,260 |
Brinker International, Inc. | | 60,305 | 2,716,137 |
Caesars Entertainment, Inc. (a) | | 20,196 | 924,977 |
Churchill Downs, Inc. | | 8,028 | 1,402,973 |
Cracker Barrel Old Country Store, Inc. | | 2,267 | 303,121 |
Dine Brands Global, Inc. | | 2,948 | 175,583 |
Marriott Vacations Worldwide Corp. | | 7,439 | 704,250 |
Penn National Gaming, Inc. (a) | | 27,157 | 1,387,723 |
PlayAGS, Inc. (a) | | 10,099 | 40,396 |
RCI Hospitality Holdings, Inc. | | 9,161 | 175,158 |
Scientific Games Corp. Class A (a) | | 55,544 | 1,148,928 |
Texas Roadhouse, Inc. Class A | | 12,401 | 781,139 |
Wingstop, Inc. | | 6,469 | 1,057,035 |
| | | 12,025,680 |
Household Durables - 2.9% | | | |
Cavco Industries, Inc. (a) | | 5,444 | 1,039,314 |
Ethan Allen Interiors, Inc. | | 30,270 | 431,045 |
Flexsteel Industries, Inc. | | 13,475 | 223,416 |
Installed Building Products, Inc. (a) | | 3,049 | 264,714 |
KB Home | | 90,055 | 3,220,367 |
La-Z-Boy, Inc. | | 53,417 | 1,736,053 |
M.D.C. Holdings, Inc. | | 38,737 | 1,680,411 |
M/I Homes, Inc. (a) | | 64,135 | 2,729,586 |
Meritage Homes Corp. (a) | | 7,335 | 704,380 |
TopBuild Corp. (a) | | 826 | 127,039 |
TRI Pointe Homes, Inc. (a) | | 104,266 | 1,760,010 |
| | | 13,916,335 |
Internet & Direct Marketing Retail - 0.9% | | | |
Overstock.com, Inc. (a) | | 6,047 | 529,113 |
PetMed Express, Inc. (b) | | 28,380 | 986,489 |
Shutterstock, Inc. | | 31,520 | 1,586,086 |
Stamps.com, Inc. (a) | | 2,487 | 620,109 |
The Rubicon Project, Inc. (a) | | 12,452 | 91,522 |
Waitr Holdings, Inc. (a) | | 116,557 | 469,725 |
| | | 4,283,044 |
Leisure Products - 0.8% | | | |
Acushnet Holdings Corp. | | 5,444 | 192,119 |
Johnson Outdoors, Inc. Class A | | 15,310 | 1,312,220 |
Malibu Boats, Inc. Class A (a) | | 14,281 | 740,470 |
Vista Outdoor, Inc. (a) | | 72,444 | 1,406,138 |
YETI Holdings, Inc. (a) | | 4,877 | 250,580 |
| | | 3,901,527 |
Specialty Retail - 3.2% | | | |
Aaron's, Inc. Class A | | 11,156 | 623,509 |
Asbury Automotive Group, Inc. (a) | | 10,856 | 1,148,456 |
Group 1 Automotive, Inc. | | 20,418 | 1,764,932 |
Haverty Furniture Companies, Inc. | | 12,530 | 264,634 |
Lumber Liquidators Holdings, Inc. (a) | | 6,211 | 149,002 |
Murphy U.S.A., Inc. (a) | | 2,532 | 341,466 |
Rent-A-Center, Inc. | | 69,845 | 2,144,242 |
RH (a)(b) | | 2,955 | 976,775 |
Sally Beauty Holdings, Inc. (a) | | 1,587 | 17,711 |
Shoe Carnival, Inc. (b) | | 42,564 | 1,399,504 |
Signet Jewelers Ltd. | | 22,916 | 395,759 |
Sleep Number Corp. (a) | | 49,445 | 2,373,360 |
Sonic Automotive, Inc. Class A (sub. vtg.) (b) | | 65,349 | 2,761,649 |
The ODP Corp. | | 31,952 | 747,038 |
| | | 15,108,037 |
Textiles, Apparel & Luxury Goods - 1.6% | | | |
Crocs, Inc. (a) | | 77,109 | 3,077,420 |
Deckers Outdoor Corp. (a) | | 18,730 | 3,818,488 |
Rocky Brands, Inc. | | 5,750 | 138,460 |
Steven Madden Ltd. | | 24,423 | 516,791 |
| | | 7,551,159 |
|
TOTAL CONSUMER DISCRETIONARY | | | 60,199,587 |
|
CONSUMER STAPLES - 2.7% | | | |
Beverages - 0.5% | | | |
Coca-Cola Bottling Co. Consolidated | | 7,047 | 1,925,945 |
MGP Ingredients, Inc. | | 6,728 | 239,180 |
| | | 2,165,125 |
Food & Staples Retailing - 0.8% | | | |
Andersons, Inc. | | 6,737 | 119,447 |
BJ's Wholesale Club Holdings, Inc. (a) | | 10,699 | 475,143 |
Ingles Markets, Inc. Class A | | 33,669 | 1,360,228 |
Natural Grocers by Vitamin Cottage, Inc. | | 20,905 | 245,007 |
Performance Food Group Co. (a) | | 2,711 | 98,979 |
PriceSmart, Inc. | | 14,670 | 964,553 |
Rite Aid Corp. (a)(b) | | 29,616 | 385,600 |
Weis Markets, Inc. (b) | | 6,527 | 321,324 |
| | | 3,970,281 |
Food Products - 0.7% | | | |
Cal-Maine Foods, Inc. (a)(b) | | 39,424 | 1,521,372 |
Darling Ingredients, Inc. (a) | | 1,728 | 55,244 |
Freshpet, Inc. (a) | | 7,637 | 867,563 |
John B. Sanfilippo & Son, Inc. | | 6,809 | 542,269 |
Lancaster Colony Corp. | | 689 | 122,449 |
Landec Corp. (a) | | 1,185 | 12,134 |
The Simply Good Foods Co. (a) | | 11,523 | 286,347 |
| | | 3,407,378 |
Household Products - 0.5% | | | |
Central Garden & Pet Co. (a) | | 2,240 | 91,146 |
Central Garden & Pet Co. Class A (non-vtg.) (a) | | 4,250 | 157,930 |
WD-40 Co. | | 9,388 | 1,918,719 |
| | | 2,167,795 |
Personal Products - 0.1% | | | |
USANA Health Sciences, Inc. (a) | | 9,137 | 716,432 |
Tobacco - 0.1% | | | |
Vector Group Ltd. | | 31,240 | 314,587 |
|
TOTAL CONSUMER STAPLES | | | 12,741,598 |
|
ENERGY - 2.0% | | | |
Energy Equipment & Services - 0.7% | | | |
Bristow Group, Inc. (a) | | 1,419 | 26,833 |
Championx Corp. (a) | | 18,245 | 186,829 |
Helix Energy Solutions Group, Inc. (a) | | 162,294 | 581,013 |
Liberty Oilfield Services, Inc. Class A | | 14,350 | 92,558 |
Nabors Industries Ltd. (b) | | 39,654 | 1,585,367 |
Newpark Resources, Inc. (a) | | 9,377 | 18,285 |
Nextier Oilfield Solutions, Inc. (a) | | 33,911 | 85,456 |
Oceaneering International, Inc. (a) | | 50,577 | 272,610 |
Oil States International, Inc. (a) | | 60,078 | 263,742 |
ProPetro Holding Corp. (a) | | 53,059 | 333,211 |
U.S. Silica Holdings, Inc. | | 35,514 | 158,392 |
| | | 3,604,296 |
Oil, Gas & Consumable Fuels - 1.3% | | | |
Antero Resources Corp. (a)(b) | | 53,830 | 173,333 |
DHT Holdings, Inc. | | 222,073 | 1,174,766 |
Falcon Minerals Corp. | | 2,346 | 6,592 |
GasLog Ltd. | | 2,568 | 7,576 |
Green Plains, Inc. (a) | | 10,242 | 137,038 |
Kosmos Energy Ltd. | | 640,273 | 941,201 |
Magnolia Oil & Gas Corp. Class A (a) | | 51,341 | 330,636 |
Matador Resources Co. (a) | | 18,854 | 183,449 |
National Energy Services Reunited Corp. (a) | | 3,710 | 27,973 |
Nordic American Tanker Shipping Ltd. (b) | | 175,529 | 765,306 |
PBF Energy, Inc. Class A | | 81,740 | 699,694 |
Penn Virginia Corp. (a)(b) | | 81,762 | 933,722 |
Range Resources Corp. | | 16,422 | 122,508 |
SM Energy Co. | | 214,362 | 520,900 |
World Fuel Services Corp. | | 6,347 | 167,561 |
| | | 6,192,255 |
|
TOTAL ENERGY | | | 9,796,551 |
|
FINANCIALS - 16.5% | | | |
Banks - 6.4% | | | |
1st Source Corp. | | 13,958 | 480,853 |
American National Bankshares, Inc. | | 1,759 | 39,648 |
Banc of California, Inc. | | 15,697 | 172,510 |
BancFirst Corp. | | 61,138 | 2,690,072 |
Bancorp, Inc., Delaware (a) | | 31,782 | 301,929 |
Boston Private Financial Holdings, Inc. | | 22,133 | 131,470 |
Brookline Bancorp, Inc., Delaware | | 7,165 | 68,784 |
Cadence Bancorp Class A | | 80,965 | 769,168 |
Capital City Bank Group, Inc. | | 3,568 | 72,323 |
Capstar Financial Holdings, Inc. | | 2,028 | 20,665 |
Cathay General Bancorp | | 76,254 | 1,882,711 |
Community Bank System, Inc. | | 2,070 | 124,552 |
Community Trust Bancorp, Inc. | | 8,199 | 264,582 |
Eagle Bancorp, Inc. | | 3,550 | 102,169 |
Financial Institutions, Inc. | | 17,596 | 303,179 |
First Bancorp, North Carolina | | 2,400 | 49,080 |
First Bancorp, Puerto Rico | | 446,704 | 2,559,614 |
First Business Finance Services, Inc. | | 1,291 | 20,011 |
First Financial Bankshares, Inc. | | 12,732 | 385,461 |
First Financial Corp., Indiana | | 4,009 | 137,870 |
First Interstate Bancsystem, Inc. | | 22,314 | 731,899 |
First of Long Island Corp. | | 4,427 | 68,021 |
Flushing Financial Corp. | | 6,545 | 79,391 |
Fulton Financial Corp. | | 184,019 | 1,799,706 |
Great Southern Bancorp, Inc. | | 26,292 | 1,013,294 |
Great Western Bancorp, Inc. | | 7,340 | 102,246 |
Hancock Whitney Corp. | | 75,459 | 1,509,935 |
Hilltop Holdings, Inc. | | 72,442 | 1,492,305 |
Hope Bancorp, Inc. | | 17,222 | 145,698 |
Independent Bank Group, Inc. | | 14,325 | 666,113 |
International Bancshares Corp. | | 83,510 | 2,637,246 |
Investors Bancorp, Inc. | | 291,193 | 2,256,746 |
Lakeland Bancorp, Inc. | | 7,993 | 84,966 |
Lakeland Financial Corp. | | 10,225 | 467,180 |
Macatawa Bank Corp. | | 3,981 | 29,141 |
Mercantil Bank Holding Corp. Class A (a) | | 544 | 7,154 |
Mercantile Bank Corp. | | 3,299 | 72,050 |
Metrocity Bankshares, Inc. | | 1,515 | 20,665 |
Nicolet Bankshares, Inc. (a) | | 2,890 | 173,458 |
OFG Bancorp | | 45,651 | 586,159 |
Old National Bancorp, Indiana | | 9,542 | 133,397 |
Park National Corp. | | 4,299 | 386,523 |
Peapack-Gladstone Financial Corp. | | 12,933 | 219,861 |
People's Utah Bancorp | | 2,534 | 52,251 |
Peoples Bancorp, Inc. | | 837 | 17,694 |
Republic Bancorp, Inc., Kentucky Class A | | 1,041 | 32,021 |
Sandy Spring Bancorp, Inc. | | 8,974 | 214,658 |
Sierra Bancorp | | 16,743 | 299,197 |
South Plains Financial, Inc. | | 428 | 6,112 |
South State Corp. | | 6,558 | 365,149 |
Southside Bancshares, Inc. | | 15,805 | 435,507 |
The First Bancorp, Inc. | | 1,283 | 27,302 |
Tompkins Financial Corp. | | 4,839 | 320,245 |
Trico Bancshares | | 8,546 | 236,639 |
Trustmark Corp. | | 7,201 | 169,079 |
UMB Financial Corp. | | 23,561 | 1,265,697 |
United Community Bank, Inc. | | 18,193 | 329,657 |
Univest Corp. of Pennsylvania | | 13,036 | 209,749 |
Valley National Bancorp | | 83,197 | 624,809 |
Washington Trust Bancorp, Inc. | | 2,943 | 98,237 |
WesBanco, Inc. | | 26,097 | 579,875 |
West Bancorp., Inc. | | 369 | 6,494 |
| | | 30,550,177 |
Capital Markets - 3.3% | | | |
Artisan Partners Asset Management, Inc. | | 80,728 | 3,124,981 |
Cohen & Steers, Inc. | | 40,091 | 2,425,506 |
Cowen Group, Inc. Class A | | 2,498 | 45,189 |
Federated Hermes, Inc. Class B (non-vtg.) | | 107,458 | 2,569,321 |
INTL FCStone, Inc. (a) | | 33,998 | 1,927,687 |
Oppenheimer Holdings, Inc. Class A (non-vtg.) | | 34,394 | 840,245 |
Piper Jaffray Companies | | 22,204 | 1,675,292 |
PJT Partners, Inc. | | 8,734 | 516,878 |
Pzena Investment Management, Inc. | | 7,411 | 36,684 |
Stifel Financial Corp. | | 4,025 | 204,108 |
Waddell & Reed Financial, Inc. Class A (b) | | 145,741 | 2,295,421 |
Westwood Holdings Group, Inc. | | 1,901 | 21,633 |
| | | 15,682,945 |
Consumer Finance - 1.1% | | | |
Enova International, Inc. (a) | | 109,732 | 1,874,223 |
LendingClub Corp. (a) | | 58,524 | 311,933 |
Nelnet, Inc. Class A | | 42,667 | 2,794,262 |
| | | 4,980,418 |
Diversified Financial Services - 0.7% | | | |
Cannae Holdings, Inc. (a) | | 81,147 | 3,061,676 |
Marlin Business Services Corp. | | 22,751 | 152,432 |
Rafael Holdings, Inc. (a) | | 2,158 | 37,592 |
| | | 3,251,700 |
Insurance - 2.7% | | | |
Amerisafe, Inc. | | 18,321 | 1,222,560 |
Crawford & Co. Class B | | 5,466 | 38,043 |
Donegal Group, Inc. Class A | | 1,760 | 25,397 |
eHealth, Inc. (a) | | 14,516 | 916,250 |
Employers Holdings, Inc. | | 10,191 | 332,023 |
Goosehead Insurance (b) | | 25,713 | 2,642,268 |
Horace Mann Educators Corp. | | 41,633 | 1,626,185 |
Investors Title Co. | | 275 | 37,417 |
National General Holdings Corp. | | 2,872 | 97,792 |
ProAssurance Corp. | | 9,759 | 149,508 |
Selective Insurance Group, Inc. | | 46,694 | 2,792,768 |
Third Point Reinsurance Ltd. (a) | | 8,932 | 76,458 |
Trupanion, Inc. (a)(b) | | 47,257 | 2,964,432 |
| | | 12,921,101 |
Mortgage Real Estate Investment Trusts - 0.0% | | | |
Invesco Mortgage Capital, Inc. (b) | | 8,987 | 26,961 |
Redwood Trust, Inc. | | 10,057 | 69,695 |
| | | 96,656 |
Thrifts & Mortgage Finance - 2.3% | | | |
Essent Group Ltd. | | 80,292 | 2,866,424 |
Farmer Mac Class C (non-vtg.) | | 9,806 | 668,279 |
First Defiance Financial Corp. | | 11,830 | 216,193 |
NMI Holdings, Inc. (a) | | 17,419 | 298,736 |
Northwest Bancshares, Inc. | | 121,869 | 1,232,096 |
Pennymac Financial Services, Inc. | | 7,700 | 405,944 |
Radian Group, Inc. | | 154,878 | 2,391,316 |
Walker & Dunlop, Inc. | | 27,713 | 1,518,118 |
Washington Federal, Inc. | | 36,378 | 853,064 |
Waterstone Financial, Inc. | | 32,805 | 508,149 |
| | | 10,958,319 |
|
TOTAL FINANCIALS | | | 78,441,316 |
|
HEALTH CARE - 19.6% | | | |
Biotechnology - 9.3% | | | |
ACADIA Pharmaceuticals, Inc. (a) | | 6,086 | 240,945 |
Adverum Biotechnologies, Inc. (a) | | 17,931 | 218,758 |
Affimed NV (a) | | 77,664 | 267,941 |
Agenus, Inc. (a) | | 101,940 | 443,949 |
Aimmune Therapeutics, Inc. (a)(b) | | 4,107 | 140,542 |
Akebia Therapeutics, Inc. (a) | | 30,224 | 314,632 |
Alector, Inc. (a) | | 3,854 | 49,794 |
Allakos, Inc. (a)(b) | | 3,337 | 298,928 |
Allogene Therapeutics, Inc. (a) | | 7,194 | 256,466 |
Amicus Therapeutics, Inc. (a) | | 49,568 | 723,693 |
AnaptysBio, Inc. (a) | | 15,596 | 270,279 |
Anika Therapeutics, Inc. (a) | | 3,356 | 128,635 |
Apellis Pharmaceuticals, Inc. (a) | | 20,335 | 626,928 |
Arcturus Therapeutics Holdings, Inc. (a) | | 7,671 | 370,049 |
Arcus Biosciences, Inc. (a) | | 16,145 | 384,251 |
Ardelyx, Inc. (a) | | 69,257 | 397,535 |
Arena Pharmaceuticals, Inc. (a) | | 10,791 | 753,428 |
Arrowhead Pharmaceuticals, Inc. (a) | | 20,794 | 878,339 |
Athenex, Inc. (a)(b) | | 16,497 | 189,551 |
AVEO Pharmaceuticals, Inc. (a) | | 8,337 | 39,684 |
Avid Bioservices, Inc. (a) | | 3,862 | 32,402 |
Biohaven Pharmaceutical Holding Co. Ltd. (a) | | 8,944 | 566,960 |
BioXcel Therapeutics, Inc. (a)(b) | | 10,187 | 415,120 |
Blueprint Medicines Corp. (a) | | 10,896 | 843,677 |
Bridgebio Pharma, Inc. (a)(b) | | 12,421 | 370,891 |
Calithera Biosciences, Inc. (a) | | 32,024 | 129,057 |
CareDx, Inc. (a) | | 3,700 | 126,355 |
Catalyst Biosciences, Inc. (a) | | 22,529 | 117,601 |
Catalyst Pharmaceutical Partners, Inc. (a) | | 64,682 | 212,157 |
ChemoCentryx, Inc. (a) | | 6,849 | 366,422 |
Chimerix, Inc. (a) | | 121,506 | 341,432 |
Clovis Oncology, Inc. (a)(b) | | 53,203 | 277,188 |
Coherus BioSciences, Inc. (a)(b) | | 33,506 | 635,609 |
Constellation Pharmaceuticals, Inc. (a) | | 12,284 | 258,578 |
Cortexyme, Inc. (a)(b) | | 5,596 | 246,056 |
Cue Biopharma, Inc. (a) | | 13,399 | 239,440 |
Cyclerion Therapeutics, Inc. (a) | | 2,954 | 20,146 |
Cytokinetics, Inc. (a) | | 5,502 | 131,828 |
CytomX Therapeutics, Inc. (a) | | 40,081 | 292,591 |
Deciphera Pharmaceuticals, Inc. (a) | | 12,537 | 564,290 |
Denali Therapeutics, Inc. (a)(b) | | 8,300 | 264,770 |
Dicerna Pharmaceuticals, Inc. (a) | | 7,554 | 139,900 |
Eagle Pharmaceuticals, Inc. (a) | | 554 | 21,983 |
Editas Medicine, Inc. (a)(b) | | 7,310 | 257,531 |
Eidos Therapeutics, Inc. (a)(b) | | 4,139 | 179,136 |
Eiger Biopharmaceuticals, Inc. (a) | | 19,561 | 218,496 |
Emergent BioSolutions, Inc. (a) | | 14,706 | 1,677,219 |
Enanta Pharmaceuticals, Inc. (a) | | 1,473 | 76,876 |
Epizyme, Inc. (a)(b) | | 31,984 | 415,792 |
Esperion Therapeutics, Inc. (a)(b) | | 2,205 | 79,601 |
Fate Therapeutics, Inc. (a) | | 26,330 | 958,412 |
FibroGen, Inc. (a) | | 26,766 | 1,199,920 |
Five Prime Therapeutics, Inc. (a) | | 25,542 | 109,064 |
Flexion Therapeutics, Inc. (a)(b) | | 26,032 | 303,533 |
Fortress Biotech, Inc. (a) | | 17,362 | 68,667 |
Global Blood Therapeutics, Inc. (a)(b) | | 1,189 | 74,645 |
GlycoMimetics, Inc. (a) | | 19,970 | 73,689 |
Gritstone Oncology, Inc. (a) | | 17,747 | 58,743 |
Halozyme Therapeutics, Inc. (a) | | 49,593 | 1,437,949 |
Heron Therapeutics, Inc. (a)(b) | | 11,317 | 161,833 |
IGM Biosciences, Inc. (a)(b) | | 4,636 | 199,348 |
ImmunoGen, Inc. (a) | | 123,910 | 458,467 |
Immunomedics, Inc. (a) | | 3,503 | 156,094 |
Inovio Pharmaceuticals, Inc. (a)(b) | | 29,060 | 348,429 |
Insmed, Inc. (a) | | 17,654 | 497,666 |
Intellia Therapeutics, Inc. (a) | | 1,826 | 39,405 |
Intercept Pharmaceuticals, Inc. (a) | | 4,638 | 231,343 |
Invitae Corp. (a)(b) | | 39,464 | 1,379,661 |
Iovance Biotherapeutics, Inc. (a) | | 5,072 | 169,050 |
Ironwood Pharmaceuticals, Inc. Class A (a)(b) | | 22,956 | 231,856 |
Kadmon Holdings, Inc. (a) | | 96,072 | 480,360 |
Karuna Therapeutics, Inc. (a) | | 1,735 | 132,554 |
Karyopharm Therapeutics, Inc. (a)(b) | | 25,578 | 389,041 |
Kindred Biosciences, Inc. (a) | | 41,694 | 206,802 |
Kodiak Sciences, Inc. (a) | | 11,060 | 581,645 |
Krystal Biotech, Inc. (a) | | 5,723 | 273,617 |
Kura Oncology, Inc. (a) | | 7,228 | 179,905 |
La Jolla Pharmaceutical Co. (a)(b) | | 55,459 | 232,928 |
Lexicon Pharmaceuticals, Inc. (a)(b) | | 75,076 | 131,383 |
Ligand Pharmaceuticals, Inc. Class B (a)(b) | | 1,635 | 166,770 |
Macrogenics, Inc. (a) | | 4,665 | 135,005 |
Madrigal Pharmaceuticals, Inc. (a) | | 374 | 40,280 |
Mersana Therapeutics, Inc. (a) | | 29,687 | 568,803 |
Minerva Neurosciences, Inc. (a)(b) | | 70,228 | 223,325 |
Mirati Therapeutics, Inc. (a) | | 9,705 | 1,449,636 |
Molecular Templates, Inc. (a) | | 16,127 | 187,234 |
Momenta Pharmaceuticals, Inc. (a) | | 36,069 | 1,881,720 |
Mustang Bio, Inc. (a) | | 66,184 | 216,422 |
Myriad Genetics, Inc. (a) | | 22,070 | 295,076 |
Natera, Inc. (a) | | 15,316 | 975,782 |
NextCure, Inc. (a)(b) | | 2,191 | 19,697 |
Novavax, Inc. (a)(b) | | 17,253 | 1,903,696 |
Oncternal Therapeutics, Inc. rights (a)(c) | | 1,148 | 0 |
Opko Health, Inc. (a)(b) | | 179,810 | 582,584 |
Organogenesis Holdings, Inc. Class A (a) | | 10,989 | 47,308 |
Oyster Point Pharma, Inc. (a) | | 5,947 | 135,354 |
Pieris Pharmaceuticals, Inc. (a) | | 42,098 | 120,400 |
Principia Biopharma, Inc. (a) | | 10,368 | 1,036,904 |
PTC Therapeutics, Inc. (a) | | 23,254 | 1,149,329 |
Puma Biotechnology, Inc. (a) | | 28,857 | 296,939 |
Radius Health, Inc. (a) | | 26,403 | 326,869 |
REGENXBIO, Inc. (a) | | 8,765 | 267,508 |
Retrophin, Inc. (a) | | 31,185 | 610,914 |
Rubius Therapeutics, Inc. (a)(b) | | 13,097 | 63,062 |
Sangamo Therapeutics, Inc. (a) | | 8,631 | 95,243 |
Selecta Biosciences, Inc. (a) | | 22,609 | 58,783 |
Seres Therapeutics, Inc. (a) | | 1,464 | 38,781 |
Sorrento Therapeutics, Inc. (a)(b) | | 6,819 | 54,620 |
Syndax Pharmaceuticals, Inc. (a) | | 15,675 | 255,659 |
TCR2 Therapeutics, Inc. (a) | | 3,593 | 72,650 |
TG Therapeutics, Inc. (a)(b) | | 40,794 | 1,011,895 |
Translate Bio, Inc. (a)(b) | | 3,805 | 53,612 |
Turning Point Therapeutics, Inc. (a) | | 3,590 | 280,666 |
Twist Bioscience Corp. (a) | | 5,502 | 384,755 |
Ultragenyx Pharmaceutical, Inc. (a) | | 11,767 | 1,000,901 |
VBI Vaccines, Inc. (a)(b) | | 5,540 | 23,600 |
Veracyte, Inc. (a) | | 5,117 | 170,447 |
Viela Bio, Inc. (b) | | 2,485 | 83,720 |
Vir Biotechnology, Inc. (a) | | 7,172 | 290,323 |
Xbiotech, Inc. (a)(b) | | 12,306 | 232,830 |
Xencor, Inc. (a) | | 7,351 | 262,798 |
Y-mAbs Therapeutics, Inc. (a) | | 3,084 | 132,705 |
| | | 44,484,045 |
Health Care Equipment & Supplies - 3.8% | | | |
Accelerate Diagnostics, Inc. (a)(b) | | 9,661 | 117,671 |
Accuray, Inc. (a) | | 75,840 | 176,707 |
Axonics Modulation Technologies, Inc. (a) | | 1,354 | 57,220 |
Cardiovascular Systems, Inc. (a) | | 56,849 | 1,857,257 |
Cerus Corp. (a) | | 64,677 | 411,992 |
ConforMis, Inc. (a)(b) | | 52,841 | 37,517 |
CryoPort, Inc. (a) | | 1,936 | 107,409 |
Genmark Diagnostics, Inc. (a) | | 150,199 | 1,948,081 |
Haemonetics Corp. (a) | | 14,228 | 1,275,682 |
Integer Holdings Corp. (a) | | 31,417 | 2,175,941 |
Invacare Corp. | | 15,863 | 107,551 |
Lantheus Holdings, Inc. (a) | | 53,255 | 714,682 |
Meridian Bioscience, Inc. (a) | | 109,438 | 1,547,453 |
Nevro Corp. (a) | | 11,236 | 1,545,399 |
Novocure Ltd. (a) | | 19,688 | 1,629,182 |
Orthofix International NV (a) | | 20,344 | 617,237 |
RTI Biologics, Inc. (a) | | 16,497 | 36,623 |
Seaspine Holdings Corp. (a) | | 4,844 | 64,474 |
Senseonics Holdings, Inc. (a) | | 15,631 | 7,339 |
Shockwave Medical, Inc. (a) | | 401 | 25,480 |
Sientra, Inc. (a) | | 123,657 | 474,843 |
SurModics, Inc. (a) | | 40,572 | 1,835,883 |
Tandem Diabetes Care, Inc. (a) | | 7,152 | 806,173 |
Wright Medical Group NV (a) | | 15,642 | 472,858 |
| | | 18,050,654 |
Health Care Providers & Services - 2.8% | | | |
Amedisys, Inc. (a) | | 2,346 | 567,497 |
Apollo Medical Holdings, Inc. (a)(b) | | 15,847 | 299,350 |
Brookdale Senior Living, Inc. (a) | | 109,739 | 301,782 |
Corvel Corp. (a) | | 28,836 | 2,393,965 |
Magellan Health Services, Inc. (a) | | 14,348 | 1,082,700 |
National Healthcare Corp. | | 25,790 | 1,642,823 |
Owens & Minor, Inc. | | 67,737 | 1,123,079 |
Patterson Companies, Inc. | | 19,735 | 572,512 |
Providence Service Corp. (a) | | 8,781 | 813,033 |
Select Medical Holdings Corp. (a) | | 101,200 | 2,031,084 |
Tenet Healthcare Corp. (a) | | 81,341 | 2,292,189 |
| | | 13,120,014 |
Health Care Technology - 1.9% | | | |
Allscripts Healthcare Solutions, Inc. (a) | | 299,137 | 2,671,293 |
HealthStream, Inc. (a) | | 6,276 | 130,007 |
HMS Holdings Corp. (a) | | 54,609 | 1,523,045 |
Inovalon Holdings, Inc. Class A (a) | | 37,510 | 928,185 |
Inspire Medical Systems, Inc. (a) | | 4,383 | 523,549 |
Nextgen Healthcare, Inc. (a) | | 159,757 | 2,118,378 |
Phreesia, Inc. (a) | | 11,310 | 356,717 |
Schrodinger, Inc. | | 956 | 57,800 |
Teladoc Health, Inc. (a)(b) | | 3,465 | 747,366 |
| | | 9,056,340 |
Life Sciences Tools & Services - 0.8% | | | |
Fluidigm Corp. (a) | | 27,030 | 212,186 |
Luminex Corp. | | 21,987 | 586,833 |
Medpace Holdings, Inc. (a) | | 10,491 | 1,361,627 |
Nanostring Technologies, Inc. (a) | | 15,668 | 634,241 |
NeoGenomics, Inc. (a) | | 20,013 | 779,506 |
| | | 3,574,393 |
Pharmaceuticals - 1.0% | | | |
Akorn, Inc. (a) | | 12,167 | 419 |
Amneal Pharmaceuticals, Inc. (a) | | 73,530 | 302,208 |
Arvinas Holding Co. LLC (a) | | 1,865 | 48,397 |
Assertio Holdings, Inc. (a) | | 92,658 | 75,053 |
Axsome Therapeutics, Inc. (a) | | 9,840 | 721,370 |
Collegium Pharmaceutical, Inc. (a) | | 8,673 | 165,307 |
Corcept Therapeutics, Inc. (a)(b) | | 4,697 | 59,652 |
Intra-Cellular Therapies, Inc. (a) | | 5,428 | 98,898 |
MyoKardia, Inc. (a) | | 12,550 | 1,373,472 |
Pacira Biosciences, Inc. (a) | | 17,887 | 1,118,295 |
Prestige Brands Holdings, Inc. (a) | | 12,177 | 443,608 |
Revance Therapeutics, Inc. (a) | | 5,994 | 175,205 |
Supernus Pharmaceuticals, Inc. (a) | | 1,574 | 34,612 |
Theravance Biopharma, Inc. (a) | | 5,466 | 100,192 |
Zogenix, Inc. (a) | | 6,146 | 145,476 |
| | | 4,862,164 |
|
TOTAL HEALTH CARE | | | 93,147,610 |
|
INDUSTRIALS - 16.0% | | | |
Aerospace & Defense - 1.5% | | | |
AAR Corp. | | 75,343 | 1,520,422 |
Aerojet Rocketdyne Holdings, Inc. (a) | | 2,263 | 93,620 |
Astronics Corp. (a) | | 52,802 | 477,330 |
Axon Enterprise, Inc. (a) | | 5,714 | 489,576 |
Maxar Technologies, Inc. | | 11,322 | 262,104 |
Moog, Inc. Class A | | 40,113 | 2,418,413 |
Parsons Corp. (a) | | 60,155 | 2,000,755 |
Vectrus, Inc. (a) | | 823 | 35,726 |
| | | 7,297,946 |
Air Freight & Logistics - 0.1% | | | |
Atlas Air Worldwide Holdings, Inc. (a) | | 10,030 | 565,592 |
Airlines - 0.1% | | | |
Spirit Airlines, Inc. (a) | | 27,117 | 484,852 |
Building Products - 2.1% | | | |
Advanced Drain Systems, Inc. | | 23,507 | 1,304,168 |
Builders FirstSource, Inc. (a) | | 6,476 | 198,295 |
Gibraltar Industries, Inc. (a) | | 10,540 | 658,170 |
Griffon Corp. | | 3,458 | 75,142 |
NCI Building Systems, Inc. (a) | | 32,734 | 260,563 |
Quanex Building Products Corp. | | 67,325 | 1,131,733 |
Resideo Technologies, Inc. (a) | | 32,794 | 438,128 |
Simpson Manufacturing Co. Ltd. | | 10,605 | 1,042,896 |
Trex Co., Inc. (a) | | 9,950 | 1,487,426 |
Ufp Industries, Inc. | | 57,295 | 3,400,458 |
| | | 9,996,979 |
Commercial Services & Supplies - 2.0% | | | |
ADS Waste Holdings, Inc. (a) | | 2,436 | 73,397 |
Brady Corp. Class A | | 43,424 | 2,036,151 |
Deluxe Corp. | | 43,751 | 1,242,528 |
Kimball International, Inc. Class B | | 148,360 | 1,663,116 |
Knoll, Inc. | | 39,894 | 513,436 |
Tetra Tech, Inc. | | 14,442 | 1,333,141 |
UniFirst Corp. (b) | | 14,525 | 2,797,806 |
VSE Corp. | | 1,466 | 42,558 |
| | | 9,702,133 |
Construction & Engineering - 1.0% | | | |
Comfort Systems U.S.A., Inc. | | 5,153 | 261,103 |
EMCOR Group, Inc. | | 47,144 | 3,536,271 |
Fluor Corp. | | 36,418 | 346,699 |
Great Lakes Dredge & Dock Corp. (a) | | 61,989 | 580,837 |
Primoris Services Corp. | | 14,701 | 280,201 |
| | | 5,005,111 |
Electrical Equipment - 3.1% | | | |
Atkore International Group, Inc. (a) | | 81,937 | 2,190,176 |
AZZ, Inc. | | 26,768 | 929,653 |
Encore Wire Corp. | | 47,182 | 2,435,063 |
EnerSys | | 45,852 | 3,300,427 |
Generac Holdings, Inc. (a) | | 4,680 | 889,106 |
Plug Power, Inc. (a)(b) | | 203,219 | 2,637,783 |
Powell Industries, Inc. | | 55,896 | 1,508,633 |
Preformed Line Products Co. | | 11,275 | 613,473 |
Thermon Group Holdings, Inc. (a) | | 2,746 | 36,137 |
| | | 14,540,451 |
Machinery - 2.3% | | | |
Albany International Corp. Class A | | 3,192 | 165,665 |
Altra Industrial Motion Corp. | | 16,537 | 645,770 |
Chart Industries, Inc. (a) | | 5,777 | 379,664 |
CIRCOR International, Inc. (a) | | 14,388 | 426,604 |
Columbus McKinnon Corp. (NY Shares) | | 4,389 | 159,650 |
EnPro Industries, Inc. | | 6,533 | 382,311 |
Evoqua Water Technologies Corp. (a) | | 39,780 | 813,899 |
Gencor Industries, Inc. (a) | | 559 | 7,049 |
Gorman-Rupp Co. | | 4,660 | 148,887 |
Hillenbrand, Inc. | | 48,031 | 1,523,063 |
Hurco Companies, Inc. | | 18,077 | 511,218 |
Hyster-Yale Materials Handling Class A | | 4,020 | 162,167 |
L.B. Foster Co. Class A (a) | | 1,955 | 29,227 |
Lydall, Inc. (a) | | 7,207 | 135,347 |
Mueller Industries, Inc. | | 34,956 | 1,038,193 |
NN, Inc. | | 5,073 | 23,082 |
Park-Ohio Holdings Corp. | | 1,266 | 20,028 |
Proto Labs, Inc. (a) | | 3,046 | 447,762 |
Rexnord Corp. | | 102,500 | 2,968,400 |
Tennant Co. | | 1,240 | 82,423 |
Watts Water Technologies, Inc. Class A | | 8,631 | 826,418 |
Welbilt, Inc. (a) | | 3,388 | 25,003 |
| | | 10,921,830 |
Marine - 0.1% | | | |
Costamare, Inc. | | 55,818 | 281,881 |
Professional Services - 1.6% | | | |
Barrett Business Services, Inc. | | 4,942 | 284,511 |
CRA International, Inc. | | 5,135 | 218,289 |
Heidrick & Struggles International, Inc. | | 60,975 | 1,318,889 |
Kforce, Inc. | | 58,828 | 2,020,154 |
Korn Ferry | | 12,815 | 390,858 |
Resources Connection, Inc. | | 166,810 | 2,050,095 |
TriNet Group, Inc. (a) | | 17,978 | 1,219,628 |
| | | 7,502,424 |
Road & Rail - 0.5% | | | |
ArcBest Corp. | | 17,654 | 597,058 |
Heartland Express, Inc. | | 10,610 | 219,468 |
Marten Transport Ltd. | | 82,813 | 1,503,884 |
| | | 2,320,410 |
Trading Companies & Distributors - 1.6% | | | |
Applied Industrial Technologies, Inc. | | 29,004 | 1,746,331 |
BMC Stock Holdings, Inc. (a) | | 14,639 | 584,389 |
GMS, Inc. (a) | | 42,352 | 1,121,904 |
Herc Holdings, Inc. (a) | | 9,459 | 387,346 |
Now, Inc. (a) | | 7,472 | 54,321 |
Rush Enterprises, Inc. Class A | | 57,772 | 2,791,543 |
Systemax, Inc. | | 34,334 | 761,871 |
WESCO International, Inc. (a) | | 488 | 22,863 |
| | | 7,470,568 |
|
TOTAL INDUSTRIALS | | | 76,090,177 |
|
INFORMATION TECHNOLOGY - 15.4% | | | |
Communications Equipment - 0.8% | | | |
Acacia Communications, Inc. (a) | | 1,912 | 129,022 |
ADTRAN, Inc. | | 21,345 | 236,716 |
Calix Networks, Inc. (a) | | 138,941 | 2,702,402 |
Comtech Telecommunications Corp. | | 4,642 | 77,057 |
Digi International, Inc. (a) | | 17,954 | 244,533 |
Extreme Networks, Inc. (a) | | 66,718 | 291,558 |
Plantronics, Inc. (b) | | 4,233 | 52,320 |
| | | 3,733,608 |
Electronic Equipment & Components - 1.8% | | | |
Badger Meter, Inc. | | 14,939 | 921,587 |
ePlus, Inc. (a) | | 6,574 | 504,357 |
Insight Enterprises, Inc. (a) | | 39,384 | 2,355,360 |
Itron, Inc. (a) | | 1,171 | 69,756 |
Kimball Electronics, Inc. (a) | | 55,108 | 743,131 |
Methode Electronics, Inc. Class A | | 31,827 | 901,022 |
PC Connection, Inc. | | 36,249 | 1,605,468 |
Sanmina Corp. (a) | | 19,782 | 559,831 |
ScanSource, Inc. (a) | | 39,616 | 978,119 |
| | | 8,638,631 |
IT Services - 1.6% | | | |
Brightcove, Inc. (a) | | 7,968 | 88,604 |
Conduent, Inc. (a) | | 34,428 | 116,367 |
CSG Systems International, Inc. | | 7,028 | 299,182 |
EVERTEC, Inc. | | 88,461 | 3,097,904 |
Limelight Networks, Inc. (a) | | 112,465 | 637,677 |
ManTech International Corp. Class A | | 8,400 | 628,740 |
Perspecta, Inc. | | 65,901 | 1,368,764 |
Sykes Enterprises, Inc. (a) | | 50,181 | 1,661,242 |
| | | 7,898,480 |
Semiconductors & Semiconductor Equipment - 4.6% | | | |
Ambarella, Inc. (a) | | 28,434 | 1,498,472 |
Amkor Technology, Inc. (a) | | 128,767 | 1,570,314 |
Cirrus Logic, Inc. (a) | | 31,451 | 1,905,616 |
Diodes, Inc. (a) | | 27,655 | 1,351,223 |
Enphase Energy, Inc. (a) | | 10,469 | 808,521 |
FormFactor, Inc. (a) | | 30,706 | 802,348 |
Inphi Corp. (a) | | 15,046 | 1,714,943 |
Lattice Semiconductor Corp. (a) | | 76,339 | 2,183,295 |
NeoPhotonics Corp. (a) | | 107,149 | 713,612 |
Photronics, Inc. (a) | | 13,215 | 132,546 |
Pixelworks, Inc. (a) | | 14,974 | 34,141 |
Power Integrations, Inc. | | 45,032 | 2,520,441 |
Rambus, Inc. (a) | | 12,049 | 161,818 |
Semtech Corp. (a) | | 5,692 | 333,836 |
Silicon Laboratories, Inc. (a) | | 25,081 | 2,568,545 |
Synaptics, Inc. (a) | | 36,380 | 3,104,305 |
Ultra Clean Holdings, Inc. (a) | | 13,502 | 331,069 |
Veeco Instruments, Inc. (a) | | 2,733 | 32,495 |
| | | 21,767,540 |
Software - 6.3% | | | |
Agilysys, Inc. (a) | | 96,193 | 2,440,416 |
AppFolio, Inc. (a)(b) | | 6,388 | 1,073,376 |
BlackLine, Inc. (a) | | 30,773 | 2,688,637 |
Box, Inc. Class A (a) | | 152,496 | 2,993,496 |
Cloudera, Inc. (a) | | 88,532 | 1,169,508 |
CommVault Systems, Inc. (a) | | 59,500 | 2,572,185 |
Cornerstone OnDemand, Inc. (a) | | 35,077 | 1,237,166 |
Digital Turbine, Inc. (a) | | 124,076 | 3,001,398 |
Domo, Inc. Class B (a) | | 29,577 | 1,204,375 |
Ebix, Inc. | | 4,839 | 111,636 |
Everbridge, Inc. (a)(b) | | 6,086 | 904,440 |
MobileIron, Inc. (a) | | 301,023 | 1,965,680 |
Progress Software Corp. | | 68,267 | 2,586,637 |
Q2 Holdings, Inc. (a) | | 28,351 | 2,758,269 |
Rimini Street, Inc. (a) | | 972 | 4,257 |
SecureWorks Corp. (a) | | 3,643 | 47,104 |
SPS Commerce, Inc. (a) | | 25,958 | 2,073,525 |
TeleNav, Inc. (a) | | 28,033 | 128,671 |
Tenable Holdings, Inc. (a) | | 8,902 | 335,071 |
Verint Systems, Inc. (a) | | 5,041 | 239,750 |
Yext, Inc. (a) | | 14,066 | 279,351 |
| | | 29,814,948 |
Technology Hardware, Storage & Peripherals - 0.3% | | | |
Avid Technology, Inc. (a)(b) | | 177,503 | 1,437,774 |
|
TOTAL INFORMATION TECHNOLOGY | | | 73,290,981 |
|
MATERIALS - 4.2% | | | |
Chemicals - 1.0% | | | |
FutureFuel Corp. | | 60,840 | 736,164 |
Hawkins, Inc. | | 1,321 | 66,341 |
PolyOne Corp. | | 43,419 | 1,108,053 |
Stepan Co. | | 24,355 | 2,807,888 |
Tronox Holdings PLC | | 34,139 | 305,885 |
| | | 5,024,331 |
Construction Materials - 0.5% | | | |
Forterra, Inc. (a) | | 179,562 | 2,379,197 |
Containers & Packaging - 0.5% | | | |
Myers Industries, Inc. | | 142,515 | 2,180,480 |
Metals & Mining - 1.5% | | | |
Coeur d'Alene Mines Corp. (a) | | 71,101 | 601,514 |
Commercial Metals Co. | | 87,821 | 1,832,824 |
Hecla Mining Co. | | 126,366 | 760,723 |
Materion Corp. | | 7,561 | 412,755 |
Novagold Resources, Inc. (a) | | 55,871 | 593,256 |
Schnitzer Steel Industries, Inc. Class A | | 2,375 | 46,883 |
Worthington Industries, Inc. | | 69,539 | 2,887,955 |
| | | 7,135,910 |
Paper & Forest Products - 0.7% | | | |
Boise Cascade Co. | | 49,432 | 2,263,986 |
Schweitzer-Mauduit International, Inc. | | 30,495 | 924,913 |
| | | 3,188,899 |
|
TOTAL MATERIALS | | | 19,908,817 |
|
REAL ESTATE - 4.8% | | | |
Equity Real Estate Investment Trusts (REITs) - 3.7% | | | |
Agree Realty Corp. | | 3,588 | 240,109 |
American Assets Trust, Inc. | | 74,407 | 1,901,099 |
Armada Hoffler Properties, Inc. | | 8,206 | 82,881 |
CareTrust (REIT), Inc. | | 15,746 | 305,000 |
CatchMark Timber Trust, Inc. | | 14,431 | 143,300 |
City Office REIT, Inc. | | 7,482 | 60,155 |
Colony Capital, Inc. | | 163,609 | 443,380 |
CoreCivic, Inc. | | 67,948 | 632,596 |
Diversified Healthcare Trust (SBI) | | 286,049 | 1,086,986 |
EastGroup Properties, Inc. | | 12,338 | 1,642,928 |
Essential Properties Realty Trust, Inc. | | 26,659 | 452,403 |
Farmland Partners, Inc. | | 10,943 | 73,209 |
Four Corners Property Trust, Inc. | | 28,223 | 712,631 |
Franklin Street Properties Corp. | | 7,733 | 34,257 |
Gladstone Land Corp. | | 9,900 | 155,826 |
Healthcare Realty Trust, Inc. | | 13,379 | 385,984 |
Hersha Hospitality Trust | | 13,276 | 85,365 |
Hospitality Properties Trust (SBI) | | 23,106 | 189,700 |
Kite Realty Group Trust | | 34,327 | 385,835 |
Monmouth Real Estate Investment Corp. Class A | | 4,219 | 61,218 |
National Storage Affiliates Trust | | 55,292 | 1,897,069 |
New Senior Investment Group, Inc. | | 44,852 | 196,452 |
Piedmont Office Realty Trust, Inc. Class A | | 12,085 | 185,021 |
Potlatch Corp. | | 1,875 | 86,325 |
Preferred Apartment Communities, Inc. Class A | | 6,590 | 43,494 |
PS Business Parks, Inc. | | 20,582 | 2,597,448 |
Retail Value, Inc. | | 1,212 | 15,405 |
RLJ Lodging Trust | | 86,066 | 812,463 |
Safety Income and Growth, Inc. | | 4,385 | 243,236 |
Seritage Growth Properties (a)(b) | | 18,558 | 260,369 |
Sunstone Hotel Investors, Inc. | | 147,957 | 1,232,482 |
Terreno Realty Corp. | | 12,841 | 765,837 |
The GEO Group, Inc. | | 29,455 | 328,718 |
| | | 17,739,181 |
Real Estate Management & Development - 1.1% | | | |
Gyrodyne LLC (a) | | 310 | 5,270 |
Kennedy-Wilson Holdings, Inc. | | 58,363 | 834,007 |
Marcus & Millichap, Inc. (a) | | 35,207 | 993,189 |
Newmark Group, Inc. | | 269,937 | 1,195,821 |
RE/MAX Holdings, Inc. | | 17,365 | 610,206 |
The RMR Group, Inc. | | 59,325 | 1,674,152 |
| | | 5,312,645 |
|
TOTAL REAL ESTATE | | | 23,051,826 |
|
UTILITIES - 2.8% | | | |
Electric Utilities - 1.2% | | | |
Allete, Inc. | | 30,634 | 1,653,011 |
MGE Energy, Inc. | | 2,507 | 162,930 |
Otter Tail Corp. | | 21,822 | 847,785 |
PNM Resources, Inc. | | 6,044 | 264,002 |
Portland General Electric Co. | | 62,656 | 2,390,326 |
Spark Energy, Inc. Class A, | | 21,824 | 200,563 |
| | | 5,518,617 |
Gas Utilities - 0.2% | | | |
New Jersey Resources Corp. | | 17,246 | 519,794 |
South Jersey Industries, Inc. | | 8,667 | 191,974 |
Southwest Gas Holdings, Inc. | | 1,086 | 68,277 |
| | | 780,045 |
Independent Power and Renewable Electricity Producers - 0.6% | | | |
Atlantic Power Corp. (a) | | 72,126 | 149,301 |
Clearway Energy, Inc. Class A | | 107,548 | 2,597,284 |
Ormat Technologies, Inc. | | 526 | 32,018 |
Sunnova Energy International, Inc. (a) | | 1,952 | 46,301 |
| | | 2,824,904 |
Multi-Utilities - 0.3% | | | |
Avista Corp. | | 30,994 | 1,142,439 |
Black Hills Corp. | | 6,303 | 353,472 |
NorthWestern Energy Corp. | | 1,654 | 85,413 |
| | | 1,581,324 |
Water Utilities - 0.5% | | | |
American States Water Co. | | 10,223 | 777,766 |
California Water Service Group | | 15,474 | 701,591 |
Consolidated Water Co., Inc. | | 4,130 | 49,684 |
Middlesex Water Co. | | 12,179 | 781,039 |
York Water Co. | | 3,651 | 166,522 |
| | | 2,476,602 |
|
TOTAL UTILITIES | | | 13,181,492 |
|
TOTAL COMMON STOCKS | | | |
(Cost $423,780,512) | | | 470,167,530 |
|
Nonconvertible Preferred Stocks - 0.0% | | | |
INDUSTRIALS - 0.0% | | | |
Trading Companies & Distributors - 0.0% | | | |
WESCO International, Inc. (a)(d) | | | |
(Cost $34,318) | | 1,295 | 35,897 |
|
Money Market Funds - 8.3% | | | |
Fidelity Cash Central Fund 0.12% (e) | | 5,236,828 | 5,237,876 |
Fidelity Securities Lending Cash Central Fund 0.11% (e)(f) | | 34,363,325 | 34,366,761 |
TOTAL MONEY MARKET FUNDS | | | |
(Cost $39,602,254) | | | 39,604,637 |
TOTAL INVESTMENT IN SECURITIES - 107.1% | | | |
(Cost $463,417,084) | | | 509,808,064 |
NET OTHER ASSETS (LIABILITIES) - (7.1)% | | | (33,846,210) |
NET ASSETS - 100% | | | $475,961,854 |
Futures Contracts | | | | | |
| Number of contracts | Expiration Date | Notional Amount | Value | Unrealized Appreciation/(Depreciation) |
Purchased | | | | | |
Equity Index Contracts | | | | | |
CME E-mini Russell 2000 Index Contracts (United States) | 77 | Sept. 2020 | $6,011,005 | $403,435 | $403,435 |
The notional amount of futures purchased as a percentage of Net Assets is 1.3%
Legend
(a) Non-income producing
(b) Security or a portion of the security is on loan at period end.
(c) Level 3 security
(d) Coupon rates for floating and adjustable rate securities reflect the rates in effect at period end.
(e) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
(f) Investment made with cash collateral received from securities on loan.
Affiliated Central Funds
Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:
Fund | Income earned |
Fidelity Cash Central Fund | $5,178 |
Fidelity Securities Lending Cash Central Fund | 185,704 |
Total | $190,882 |
Amounts in the income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line-item in the Statement of Operations, if applicable. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
The value, beginning of period, for the Fidelity Securities Lending Cash Central Fund was $33,038,493. Net realized gain (loss) and change in net unrealized appreciation (depreciation) was $(1,138) and $(4), respectively. Purchases and sales of the Fidelity Securities Lending Cash Central Fund were $114,152,386 and $112,822,976, respectively, during the period.
Investment Valuation
The following is a summary of the inputs used, as of August 31, 2020, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.
| Valuation Inputs at Reporting Date: |
Description | Total | Level 1 | Level 2 | Level 3 |
Investments in Securities: | | | | |
Equities: | | | | |
Communication Services | $10,317,575 | $10,317,575 | $-- | $-- |
Consumer Discretionary | 60,199,587 | 60,199,587 | -- | -- |
Consumer Staples | 12,741,598 | 12,741,598 | -- | -- |
Energy | 9,796,551 | 9,796,551 | -- | -- |
Financials | 78,441,316 | 78,441,316 | -- | -- |
Health Care | 93,147,610 | 93,147,610 | -- | -- |
Industrials | 76,126,074 | 76,126,074 | -- | -- |
Information Technology | 73,290,981 | 73,290,981 | -- | -- |
Materials | 19,908,817 | 19,908,817 | -- | -- |
Real Estate | 23,051,826 | 23,051,826 | -- | -- |
Utilities | 13,181,492 | 13,181,492 | -- | -- |
Money Market Funds | 39,604,637 | 39,604,637 | -- | -- |
Total Investments in Securities: | $509,808,064 | $509,808,064 | $-- | $-- |
Derivative Instruments: | | | | |
Assets | | | | |
Futures Contracts | $403,435 | $403,435 | $-- | $-- |
Total Assets | $403,435 | $403,435 | $-- | $-- |
Total Derivative Instruments: | $403,435 | $403,435 | $-- | $-- |
Value of Derivative Instruments
The following table is a summary of the Fund's value of derivative instruments by primary risk exposure as of August 31, 2020. For additional information on derivative instruments, please refer to the Derivative Instruments section in the accompanying Notes to Financial Statements.
Primary Risk Exposure / Derivative Type | Value |
| Asset | Liability |
Equity Risk | | |
Futures Contracts(a) | $403,435 | $0 |
Total Equity Risk | 403,435 | 0 |
Total Value of Derivatives | $403,435 | $0 |
(a) Reflects gross cumulative appreciation (depreciation) on futures contracts as presented in the Schedule of Investments. In the Statement of Assets and Liabilities, the period end daily variation margin is included in receivable or payable for daily variation margin on futures contracts, and the net cumulative appreciation (depreciation) is included in Total accumulated earnings (loss).
See accompanying notes which are an integral part of the financial statements.
Financial Statements
Statement of Assets and Liabilities
| | August 31, 2020 (Unaudited) |
Assets | | |
Investment in securities, at value (including securities loaned of $33,352,332) — See accompanying schedule: Unaffiliated issuers (cost $423,814,830) | $470,203,427 | |
Fidelity Central Funds (cost $39,602,254) | 39,604,637 | |
Total Investment in Securities (cost $463,417,084) | | $509,808,064 |
Segregated cash with brokers for derivative instruments | | 481,400 |
Cash | | 17,523 |
Receivable for investments sold | | 5,103,721 |
Receivable for fund shares sold | | 538,846 |
Dividends receivable | | 563,842 |
Distributions receivable from Fidelity Central Funds | | 43,810 |
Total assets | | 516,557,206 |
Liabilities | | |
Payable for investments purchased | $4,318,204 | |
Payable for fund shares redeemed | 1,527,247 | |
Accrued management fee | 258,430 | |
Payable for daily variation margin on futures contracts | 59,189 | |
Other payables and accrued expenses | 71,666 | |
Collateral on securities loaned | 34,360,616 | |
Total liabilities | | 40,595,352 |
Net Assets | | $475,961,854 |
Net Assets consist of: | | |
Paid in capital | | $454,712,685 |
Total accumulated earnings (loss) | | 21,249,169 |
Net Assets | | $475,961,854 |
Net Asset Value, offering price and redemption price per share ($475,961,854 ÷ 39,436,039 shares) | | $12.07 |
See accompanying notes which are an integral part of the financial statements.
Statement of Operations
| | Six months ended August 31, 2020 (Unaudited) |
Investment Income | | |
Dividends | | $3,536,043 |
Income from Fidelity Central Funds (including $185,704 from security lending) | | 190,882 |
Total income | | 3,726,925 |
Expenses | | |
Management fee | $1,414,363 | |
Independent trustees' fees and expenses | 1,515 | |
Miscellaneous | 8,293 | |
Total expenses before reductions | 1,424,171 | |
Expense reductions | (341) | |
Total expenses after reductions | | 1,423,830 |
Net investment income (loss) | | 2,303,095 |
Realized and Unrealized Gain (Loss) | | |
Net realized gain (loss) on: | | |
Investment securities: | | |
Unaffiliated issuers | (10,650,596) | |
Fidelity Central Funds | (1,986) | |
Futures contracts | 403,392 | |
Total net realized gain (loss) | | (10,249,190) |
Change in net unrealized appreciation (depreciation) on: | | |
Investment securities: | | |
Unaffiliated issuers | 30,346,219 | |
Fidelity Central Funds | (354) | |
Futures contracts | 785,358 | |
Total change in net unrealized appreciation (depreciation) | | 31,131,223 |
Net gain (loss) | | 20,882,033 |
Net increase (decrease) in net assets resulting from operations | | $23,185,128 |
See accompanying notes which are an integral part of the financial statements.
Statement of Changes in Net Assets
| Six months ended August 31, 2020 (Unaudited) | Year ended February 29, 2020 |
Increase (Decrease) in Net Assets | | |
Operations | | |
Net investment income (loss) | $2,303,095 | $5,952,818 |
Net realized gain (loss) | (10,249,190) | (222,927) |
Change in net unrealized appreciation (depreciation) | 31,131,223 | (58,998,241) |
Net increase (decrease) in net assets resulting from operations | 23,185,128 | (53,268,350) |
Distributions to shareholders | – | (5,905,233) |
Share transactions | | |
Proceeds from sales of shares | 29,839,079 | 51,342,519 |
Reinvestment of distributions | – | 5,607,999 |
Cost of shares redeemed | (93,022,852) | (182,987,536) |
Net increase (decrease) in net assets resulting from share transactions | (63,183,773) | (126,037,018) |
Total increase (decrease) in net assets | (39,998,645) | (185,210,601) |
Net Assets | | |
Beginning of period | 515,960,499 | 701,171,100 |
End of period | $475,961,854 | $515,960,499 |
Other Information | | |
Shares | | |
Sold | 2,992,845 | 4,135,743 |
Issued in reinvestment of distributions | – | 426,140 |
Redeemed | (9,168,951) | (14,743,945) |
Net increase (decrease) | (6,176,106) | (10,182,062) |
See accompanying notes which are an integral part of the financial statements.
Financial Highlights
Fidelity Small Cap Enhanced Index Fund
| Six months ended (Unaudited) August 31, | Years endedFebruary 28, | | | | |
| 2020 | 2020 A | 2019 | 2018 | 2017 | 2016 A |
Selected Per–Share Data | | | | | | |
Net asset value, beginning of period | $11.31 | $12.57 | $13.81 | $14.32 | $10.99 | $13.05 |
Income from Investment Operations | | | | | | |
Net investment income (loss)B | .05 | .12 | .11 | .13 | .12 | .11 |
Net realized and unrealized gain (loss) | .71 | (1.26) | .31 | .55 | 3.31 | (1.52) |
Total from investment operations | .76 | (1.14) | .42 | .68 | 3.43 | (1.41) |
Distributions from net investment income | – | (.12) | (.12) | (.13) | (.10) | (.09) |
Distributions from net realized gain | – | – | (1.54) | (1.06) | – | (.56) |
Total distributions | – | (.12) | (1.66) | (1.19) | (.10) | (.65) |
Redemption fees added to paid in capitalB | – | – | – | – | –C | –C |
Net asset value, end of period | $12.07 | $11.31 | $12.57 | $13.81 | $14.32 | $10.99 |
Total ReturnD,E | 6.72% | (9.18)% | 4.01% | 4.95% | 31.15% | (11.20)% |
Ratios to Average Net AssetsF,G | | | | | | |
Expenses before reductions | .64%H | .64% | .64% | .64% | .67% | .67% |
Expenses net of fee waivers, if any | .64%H | .64% | .64% | .64% | .67% | .67% |
Expenses net of all reductions | .64%H | .64% | .64% | .64% | .67% | .67% |
Net investment income (loss) | 1.04%H | .94% | .84% | .89% | .93% | .90% |
Supplemental Data | | | | | | |
Net assets, end of period (000 omitted) | $475,962 | $515,960 | $701,171 | $762,811 | $1,210,189 | $529,009 |
Portfolio turnover rateI | 45%H | 79% | 88% | 100% | 76% | 87% |
A For the year ended February 29.
B Calculated based on average shares outstanding during the period.
C Amount represents less than $.005 per share.
D Total returns for periods of less than one year are not annualized.
E Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.
F Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.
G Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment advisor, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.
H Annualized
I Amount does not include the portfolio activity of any underlying Fidelity Central Funds.
See accompanying notes which are an integral part of the financial statements.
Notes to Financial Statements (Unaudited)
For the period ended August 31, 2020
1. Organization.
Fidelity Small Cap Enhanced Index Fund (the Fund) is a fund of Fidelity Commonwealth Trust II (the Trust) and is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Delaware statutory trust.
2. Significant Accounting Policies.
The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services – Investment Companies. The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The following summarizes the significant accounting policies of the Fund:
Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee.
The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:
- Level 1 – quoted prices in active markets for identical investments
- Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
- Level 3 – unobservable inputs (including the Fund's own assumptions based on the best information available)
Valuation techniques used to value the Fund's investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of August 31, 2020 is included at the end of the Fund's Schedule of Investments.
Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain.
Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.
Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction.
Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP.
Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.
Book-tax differences are primarily due to futures contracts, passive foreign investment companies (PFIC), market discount, partnerships (including allocations from Fidelity Central Funds), and losses deferred due to wash sales and excise tax regulations.
As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:
Gross unrealized appreciation | $94,708,153 |
Gross unrealized depreciation | (49,409,631) |
Net unrealized appreciation (depreciation) | $45,298,522 |
Tax cost | $464,912,977 |
Capital loss carryforwards are only available to offset future capital gains of the Fund to the extent provided by regulations and may be limited. The capital loss carryforward information presented below, including any applicable limitation, is estimated as of prior fiscal period end and is subject to adjustment.
No expiration | |
Short-term | $(15,755,779) |
The fund intends to elect to defer to its next fiscal year $214,137 of ordinary losses recognized during the period January 1, 2020 to February 29,2020.
3. Derivative Instruments.
Risk Exposures and the Use of Derivative Instruments. The Fund's investment objective allows the Fund to enter into various types of derivative contracts, including futures contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.
The Fund used derivatives to increase returns and to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.
The Fund's use of derivatives increased or decreased its exposure to the following risk:
Equity Risk | Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment. |
The Fund is also exposed to additional risks from investing in derivatives, such as liquidity risk and counterparty credit risk. Liquidity risk is the risk that the Fund will be unable to close out the derivative in the open market in a timely manner. Counterparty credit risk is the risk that the counterparty will not be able to fulfill its obligation to the Fund. Counterparty credit risk related to exchange-traded futures contracts may be mitigated by the protection provided by the exchange on which they trade.
Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received and amounts recognized in the Statement of Assets and Liabilities. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.
Futures Contracts. A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a fixed price at a specified future date. The Fund used futures contracts to manage its exposure to the stock market.
Upon entering into a futures contract, a fund is required to deposit either cash or securities (initial margin) with a clearing broker in an amount equal to a certain percentage of the face value of the contract. Futures contracts are marked-to-market daily and subsequent daily payments (variation margin) are made or received by a fund depending on the daily fluctuations in the value of the futures contracts and are recorded as unrealized appreciation or (depreciation). This receivable and/or payable, if any, is included in daily variation margin on futures contracts in the Statement of Assets and Liabilities. Realized gain or (loss) is recorded upon the expiration or closing of a futures contract. The net realized gain (loss) and change in net unrealized appreciation (depreciation) on futures contracts during the period is presented in the Statement of Operations.
Any open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The notional amount at value reflects each contract's exposure to the underlying instrument or index at period end and is representative of volume of activity during the period. Cash deposited to meet initial margin requirements is presented as segregated cash with brokers for derivative instruments in the Statement of Assets and Liabilities.
4. Purchases and Sales of Investments.
Purchases and sales of securities, other than short-term securities are noted in the table below.
| Purchases ($) | Sales ($) |
Fidelity Small Cap Enhanced Index Fund | 101,697,055 | 159,376,902 |
5. Fees and Other Transactions with Affiliates.
Management Fee. Fidelity Management & Research Company LLC(the investment adviser) and its affiliates provide the Fund with investment management related services for which the Fund pays a monthly management fee. The Fund pays an all-inclusive management fee based on annual rate of .64% of the Fund's average net assets; and the investment adviser pays all ordinary operating expenses of the Fund, except fees and expenses of the independent Trustees and certain miscellaneous expenses such as proxy and shareholder meeting expenses. The management fee is reduced by an amount equal to the fees and expenses paid by the Fund to the independent Trustees.
Sub-Adviser. Geode Capital Management, LLC (Geode), serves as sub-adviser for the Funds. Geode provides discretionary investment advisory services to the Funds and is paid by the investment adviser for providing these services.
Interfund Trades. Funds may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Interfund trades are included within the respective purchases and sales amounts shown in the Purchases and Sales of Investments note.
6. Investments in Fidelity Central Funds.
The Fund invests in Fidelity Central Funds, which are open-end investment companies available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Fund's Schedule of Investments lists each of the Fidelity Central Funds held as of period end, if any, as an investment of the Fund, but does not include the underlying holdings of each Fidelity Central Fund. As an Investing Fund, the Fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.
The Fidelity Money Market Central Funds are managed by FMR. Annualized expenses of the Money Market Central Funds as of their most recent shareholder report date ranged from less than .005% to .01%.
A complete unaudited list of holdings for each Fidelity Central Fund is available upon request or at the Securities and Exchange Commission (the SEC) website at www.sec.gov. In addition, the financial statements of the Fidelity Central Funds are available on the SEC website or upon request.
7. Committed Line of Credit.
Certain Funds participate with other funds managed by the investment adviser or an affiliate in a $4.25 billion credit facility (the "line of credit") to be utilized for temporary or emergency purposes to fund shareholder redemptions or for other short-term liquidity purposes. The participating funds have agreed to pay commitment fees on their pro-rata portion of the line of credit, which are reflected in Miscellaneous expenses on the Statement of Operations, and are as follows:
| Amount |
Fidelity Small Cap Enhanced Index Fund | $612 |
During the period, there were no borrowings on this line of credit.
8. Security Lending.
The Fund lends portfolio securities from time to time in order to earn additional income. Lending agents are used, including National Financial Services (NFS), an affiliate of the Fund. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of daily lending revenue, for its services as lending agent. The Fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, the Fund receives collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the market value of the loaned securities during the period of the loan. The market value of the loaned securities is determined at the close of business of the Fund and any additional required collateral is delivered to the Fund on the next business day. The Fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, the Fund may apply collateral received from the borrower against the obligation. The Fund may experience delays and costs in recovering the securities loaned. Any cash collateral received is invested in the Fidelity Securities Lending Cash Central Fund. The value of loaned securities and cash collateral at period end are disclosed on the Fund's Statement of Assets and Liabilities. The value of securities loaned to NFS, as affiliated borrower, at period end was $493,533. Total fees paid by the Fund to NFS, as lending agent, amounted to $16,330. Security lending income represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities. Net income from the Fidelity Securities Lending Cash Central Fund during the period is presented in the Statement of Operations as a component of income from Fidelity Central Funds (and includes $14,213 from securities loaned to NFS, as affiliated borrower).
9. Expense Reductions.
Through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses by $341.
10. Other.
The Fund's organizational documents provide former and current trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Fund. In the normal course of business, the Fund may also enter into contracts that provide general indemnifications. The Fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against the Fund. The risk of material loss from such claims is considered remote.
11. Coronavirus (COVID-19) Pandemic.
An outbreak of COVID-19 first detected in China during December 2019 has since spread globally and was declared a pandemic by the World Health Organization during March 2020. Developments that disrupt global economies and financial markets, such as the COVID-19 pandemic, may magnify factors that affect the Fund's performance.
Shareholder Expense Example
As a shareholder, you incur two types of costs: (1) transaction costs, which may include sales charges (loads) on purchase payments or redemption proceeds, as applicable and (2) ongoing costs, which generally include management fees, distribution and/or service (12b-1) fees and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in a fund and to compare these costs with the ongoing costs of investing in other mutual funds.
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (March 1, 2020 to August 31, 2020).
Actual Expenses
The first line of the accompanying table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000.00 (for example, an $8,600 account value divided by $1,000.00 = 8.6), then multiply the result by the number in the first line for a class/Fund under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period. If any fund is a shareholder of any underlying mutual funds or exchange-traded funds (ETFs) (the Underlying Funds), such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses incurred presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.
Hypothetical Example for Comparison Purposes
The second line of the accompanying table provides information about hypothetical account values and hypothetical expenses based on the actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. If any fund is a shareholder of any Underlying Funds, such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses as presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.
| Annualized Expense Ratio-A | Beginning Account Value March 1, 2020 | Ending Account Value August 31, 2020 | Expenses Paid During Period-B March 1, 2020 to August 31, 2020 |
Fidelity Small Cap Enhanced Index Fund | .64% | | | |
Actual | | $1,000.00 | $1,067.20 | $3.33 |
Hypothetical-C | | $1,000.00 | $1,021.98 | $3.26 |
A Annualized expense ratio reflects expenses net of applicable fee waivers.
B Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/ 365 (to reflect the one-half year period). The fees and expenses of any Underlying Funds are not included in each annualized expense ratio.
C 5% return per year before expenses
Proxy Voting Results
A special meeting of shareholders was held on June 9, 2020. The results of votes taken among shareholders on the proposal before them are reported below. Each vote reported represents one dollar of net asset value held on the record date for the meeting.
PROPOSAL 1
To elect a Board of Trustees.
| # of Votes | % of Votes |
Dennis J. Dirks |
Affirmative | 5,574,535,287.469 | 92.763 |
Withheld | 434,874,126.147 | 7.237 |
TOTAL | 6,009,409,413.616 | 100.000 |
Donald F. Donahue |
Affirmative | 5,580,170,513.183 | 92.857 |
Withheld | 429,238,900.432 | 7.143 |
TOTAL | 6,009,409,413.616 | 100.000 |
Bettina Doulton |
Affirmative | 5,613,263,967.947 | 93.408 |
Withheld | 396,145,445.669 | 6.592 |
TOTAL | 6,009,409,413.616 | 100.000 |
Vicki L. Fuller |
Affirmative | 5,634,796,072.779 | 93.766 |
Withheld | 374,613,340.837 | 6.234 |
TOTAL | 6,009,409,413.616 | 100.00 |
Patricia L. Kampling |
Affirmative | 5,595,247,247.638 | 93.108 |
Withheld | 414,162,165.978 | 6.892 |
TOTAL | 6,009,409,413.616 | 100.000 |
Alan J. Lacy |
Affirmative | 5,547,430,383.934 | 92.312 |
Withheld | 461,979,029.681 | 7.688 |
TOTAL | 6,009,409,413.616 | 100.000 |
Ned C. Lautenbach |
Affirmative | 5,444,850,891.997 | 90.605 |
Withheld | 564,558,521.619 | 9.395 |
TOTAL | 6,009,409,413.616 | 100.000 |
Robert A. Lawrence |
Affirmative | 5,556,314,439.390 | 92.460 |
Withheld | 453,094,974.226 | 7.540 |
TOTAL | 6,009,409,413.616 | 100.000 |
Joseph Mauriello |
Affirmative | 5,511,594,508.749 | 91.716 |
Withheld | 497,814,904.867 | 8.284 |
TOTAL | 6,009,409,413.616 | 100.000 |
Cornelia M. Small |
Affirmative | 5,567,879,551.358 | 92.653 |
Withheld | 441,529,862.258 | 7.347 |
TOTAL | 6,009,409,413.616 | 100.000 |
Garnett A. Smith |
Affirmative | 5,533,904,369.353 | 92.087 |
Withheld | 475,505,044.262 | 7.913 |
TOTAL | 6,009,409,413.616 | 100.000 |
David M. Thomas |
Affirmative | 5,540,360,344.547 | 92.195 |
Withheld | 469,049,069.069 | 7.805 |
TOTAL | 6,009,409,413.616 | 100.000 |
Susan Tomasky |
Affirmative | 5,600,660,192.156 | 93.198 |
Withheld | 408,749,221.459 | 6.802 |
TOTAL | 6,009,409,413.616 | 100.000 |
Michael E. Wiley |
Affirmative | 5,540,897,405.806 | 92.204 |
Withheld | 468,512,007.810 | 7.796 |
TOTAL | 6,009,409,413.616 | 100.000 |
|
Proposal 1 reflects trust wide proposal and voting results. |
SCE-SANN-1020
1.9885267.103